Novel Genetic Variants for Cartilage Thickness and Hip Osteoarthritis

PLoS Genet. 2016 Oct 4;12(10):e1006260. doi: 10.1371/journal.pgen.1006260. eCollection 2016 Oct.

Abstract

Osteoarthritis is one of the most frequent and disabling diseases of the elderly. Only few genetic variants have been identified for osteoarthritis, which is partly due to large phenotype heterogeneity. To reduce heterogeneity, we here examined cartilage thickness, one of the structural components of joint health. We conducted a genome-wide association study of minimal joint space width (mJSW), a proxy for cartilage thickness, in a discovery set of 13,013 participants from five different cohorts and replication in 8,227 individuals from seven independent cohorts. We identified five genome-wide significant (GWS, P≤5·0×10-8) SNPs annotated to four distinct loci. In addition, we found two additional loci that were significantly replicated, but results of combined meta-analysis fell just below the genome wide significance threshold. The four novel associated genetic loci were located in/near TGFA (rs2862851), PIK3R1 (rs10471753), SLBP/FGFR3 (rs2236995), and TREH/DDX6 (rs496547), while the other two (DOT1L and SUPT3H/RUNX2) were previously identified. A systematic prioritization for underlying causal genes was performed using diverse lines of evidence. Exome sequencing data (n = 2,050 individuals) indicated that there were no rare exonic variants that could explain the identified associations. In addition, TGFA, FGFR3 and PIK3R1 were differentially expressed in OA cartilage lesions versus non-lesioned cartilage in the same individuals. In conclusion, we identified four novel loci (TGFA, PIK3R1, FGFR3 and TREH) and confirmed two loci known to be associated with cartilage thickness.The identified associations were not caused by rare exonic variants. This is the first report linking TGFA to human OA, which may serve as a new target for future therapies.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Cartilage / pathology
  • Class Ia Phosphatidylinositol 3-Kinase
  • Female
  • Genetic Heterogeneity
  • Genetic Predisposition to Disease
  • Genome-Wide Association Study
  • Hip Joint / physiopathology
  • Humans
  • Male
  • Middle Aged
  • Osteoarthritis, Hip / genetics*
  • Osteoarthritis, Hip / pathology
  • Phosphatidylinositol 3-Kinases / genetics*
  • Polymorphism, Single Nucleotide
  • Receptor, Fibroblast Growth Factor, Type 3 / genetics*
  • Regulatory Sequences, Nucleic Acid / genetics
  • Transforming Growth Factor alpha / genetics*
  • Trehalase / genetics*

Substances

  • TGFA protein, human
  • Transforming Growth Factor alpha
  • PIK3R1 protein, human
  • Class Ia Phosphatidylinositol 3-Kinase
  • FGFR3 protein, human
  • Receptor, Fibroblast Growth Factor, Type 3
  • Trehalase